Interview with Tomas Luke Marcelo G. Agana III, President & CEO, PHAREX…
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
Address: Units 101-102 G/F Building Alpha, P-AyalaLand TechnoHub, Commonwealth Avenue, Diliman, Quezon City,Philippines
Tel: (632) 433-8088
Web: http://www.pharexhealth.com/
PHAREX HealthCorp, a wholly-owned subsidiary of Pascual Laboratories, Inc., was formally established in April 1972 as the exclusive marketing, sales and distribution arm of Pascual Laboratories, Inc. (Pascuallab). As a matter of fact, PHAREX is short for Pharmaceutical Excellence – the very foundation on which the venture is built.
When Pascuallab formally appointed Metro Drug as its exclusive distributor of brands in 1987, PHAREX then secured the marketing of its generic medicines. The move was timely. Soon after, the Generics Act of 1988 was enforced.
Currently, distribution for PHAREX HealthCorp is handled by Zuellig Pharma.
PHAREX HealthCorp has maintained a strong presence in the Philippine generic pharmaceutical industry for over 20 years. Pioneers in the promotion of company or uni-branded medicines, PHAREX has since grown into one of the industry’s most trusted and prescribed brands.
PHAREX offers premium quality, affordable medicines to millions of Filipinos every day.
PHAREX continues to market products owned and manufactured by Pascuallab: this includes 34 products in 22 Therapeutic Categories, including Chronic Care and Wellness.
Mr. Agana, you have been in Pharex HealthCorp for more than twenty years. Can you give to our readers an overview of Pharex and what have been the main achievements…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into…
Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities.…
Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in…
Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that…
Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country. He also expands on the…
Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based…
See our Cookie Privacy Policy Here